SlideShare a Scribd company logo
1
Understanding the Basics of Psychopharmacology
Andrew Blalock, Ph.D. Positive Impact, January 2015
WHY THIS TRAINING?
 Depression inhighrisk populations,>2foldincrease
 PTSD high-riskpopulations:women,prisoners,minorities
 Dementia decreased withART,butprevalence of MCMD andHAD?
 Bipolar primary& secondary, 10 x higher
 Schizophrenia inat-riskpopulation, 2-10x higher
PRIMARY NEUROTRANSMITTER SYSTEMS
PARTI: Commonly PrescribedMedications (listsare not exhaustive)
ANTIDEPRESSANTS
Oldermedicationslike tricyclicantidepressants (TCAs) and monoamineoxidase inhibitors (MAOIs)are rarelyused
anymore,though TCAsare nowusedfornon-specificorpsychogenicpaindisorders. We typicallydonotsee these meds
regularly here atPI.
*= lowestrates of studiedinteractionswith various HIV meds;some are insufficientlystudiedtodate
Selectiveserotoninreuptakeinhibitors (SSRIs)workbyincreasingthe amountof serotonin,the neurotransmittermost
associatedwithmood.
 Citalopram(Celexa)*
 Escitalopram(Lexapro)*
 Paroxetine (Paxil)
 Fluoxetine (Prozac)
 Fluvoxamine (Luvox)
2
 Sertraline (Zoloft)*
 Side Effects:Sexual problemsincludinglow sexdrive,ED, orinabilitytohave anorgasmare commonbut often
reversible,dizziness,headaches,nausearightafteradose,insomnia,feelingjittery;some inducedmania(rare)
Serotonin-norepinephrine reuptake inhibitors (SNRIs);increase the levelsof the neurotransmittersserotoninand
norepinephrineinthe brain.
 Desvenlafaxine (Pristiq)
 Duloxetine (Cymbalta)
 Venlafaxine(Effexor)
 Side Effects:drowsiness,fatigue,blurredvision,lightheadedness, strange dreams,constipation,fever/chills,
headache,drymouth,nausea,+/- appetite,sweating,BPchange (Cymbalta)
Serotonin modulatorsandstimulators (SMSs);thesedrugsactpartly as serotoninreuptakeinhibitors andagonize or
antagonize various serotoninreceptors.
 Vilazodone(Viibryd)
 Vortioxetine(Brintellix)
Others
 Remeron(Mirtazapine)
 Wellbutrin(Buproprion)
 Buspar (Buspione)
 Ketamine
 Almostanymedicationinvolvedwithserotoninregulationhasthe potentialtocause serotonintoxicity
(serotonin syndrome) –markedbysome of the following: mania,restlessness,agitation,emotionallability,
insomniaandconfusion. Althoughserious,itisnotcommon,generallyonlyappearingathighdosesorwhile on
othermedications.
 Pregnancycontraindications –determiningextentisdifficultaspregnanciesduringdepressionare atsome risk
anyway.
 Discontinuationsyndrome –veryrare withnewermedications(v.TCAsandMAOIs).
 Suicidal thoughts/behaviors –rare, butreported,esp.inthose under24yo;overall though,+ outweigh -.
MOOD STABILIZERS
These are usedto treat mooddisorders characterizedbyintense andsustainedmoodshifts, typically bipolardisorder,
but alsoother/similarcyclicmooddisturbances.AlsousedintreatingborderlinePDandschizoaffective disorder.Mood
stabilizers includemineral,anticonvulsant,andantipsychoticmedications.
 Lithium-- needlabworkforlevels (therapeuticrange:0.6or 0.8-1.2 mEq/L)
 Lamictal (Lamotrigine)
 Tegretol (Carbamazepine)
 Depakene (Valproicacid),Depakote (divalproex sodium)
 Trileptal (Oxcarbazepine)
 Atypical Antipsychotics -- refertosubsequentsection
 Side effects:verymedspecificrangingfromlithiumtoxicityto skinconditionsandWBC.
 Combinationtherapy(atypical antipsychoticwithlithiumorvalproate) showsbetterefficacyovermonotherapy
inthe manicphase.
 Most moodstabilizersare primarilyanti-manicagents,meaningthattheyare effective attreating maniaand
moodcyclingand shifting,butare noteffectiveattreatingacute depression.Exceptions (becausetheytreat
both) include lithium, Lamictal,andSeroquel.
 Still,antidepressants are oftenprescribedinadditiontomoodstabilizersduringdepressivephases.
3
ANXIOLYTICS
Whenyouare anxious,yourbrainbecomesmore active andnaturallyproducesachemical called gamma-aminobutyric
acid (GABA) tomake youfeel calmer.Mostanxiolyticsworkbyboostingthisprocesshelpingtoproduce a feelingof
calm,peace and overall safety. Alcohol alsoworksonGABA whichiswhyitis a primaryself-medicatingchoice for
anxiety.
Benzodiazepines
 Alprazolam(Xanax) - avoid
 Chlordiazepoxide(Librium)
 Clonazepam(Klonopin)*
 Clorazepate (Tranxene)
 Diazepam(Valium)
 Lorazepam(Ativan)*
 Oxazepam(Serax)*
 Temazepam(Restoril)*
 Triazolam(Halcion) –avoid
 Also,some SSRIs,Hydroxyzine,BetaBlockers,Neurontin;5-6othersrarelyusedandoftennot inUS
 Shiftseemstobe awayfrom benzos due todependenceissues (especiallythose thatactquicklylike Xanax)
otherthan foracute anxietyorinlowerdoses orin some alcohol detox protocols;Rx prn longterm?
 More commonside effects,especiallyof highdoses, include drowsiness,headaches,memoryproblems(inhigh
dosescan cause amnesticsyndromes),dizziness,feeling‘numb’,depersonalization/derealization,and
dependence oraddiction. There isariskof a benzodiazepine withdrawalandreboundsyndromeafter
continuoususage forlongerthantwoweeks,andtolerance anddependencemayoccurif patientsstayunder
thistreatmentforlonger
ANTIPSYCHOTICS
Antipsychoticsworkbyalteringthe effectof neurotransmitters:serotonin,noradrenaline,andacetylcholine;however,
dopamine isthe mainchemical thatthese medicines affect.Theycansuppressorprevent positive symptomslike a/v
hallucinations,delusions,thoughtdisorder(associatedwithpsychoticspectrumdisorders),andextreme moodswings
(associatedwithbipolardisorder).Firstgenerationones,introducedin1950s and used until early1990s were powerful
tranquilizersassociatedwithadverse neurologicalside effects(TDandEPS – postural andmovementdisorders). Nowin
additiontotreatingpsychoticsyndromes,theyare alsousedasadjunctive therapies(usuallyinlowerdoses) withan
antidepressantformooddisorders.
Atypicals - second generation
 Aripiprazole(Abilify)
 Lurasidone (Latuda)
 Olanzapine (Zyprexa)
 Quetiapine (Seroquel)
 Risperidone(Risperdal)
 Ziprasidone (Geodon)
 Asenapine (Saphris)
 Paliperidone (Invega)
 Side Effects: all atypical antipsychoticscarrythe possible riskforcausingweightgainandraisingbloodsugar,
cholesterol,andtriglyceride levels,whichmustbe periodicallymonitoredduringtreatment. Some antipsychotics
-- typical and atypical -- can cause heartrhythm problemsthatmayrequire monitoringbyadoctor.
4
HYPNOTICS(sleep)
Alsocalledsoporificdrugs,thisisa classof psychoactive drugs whose primaryfunctionisto induce sleep andtobe used
inthe treatmentof insomnia,earlyandmiddle. Include barbituates,quinazolinones,benzodiazepines,atypical
antipsychotics,antidepressants,antihistamines,andthese more familiar:
 Zolpidem(Ambien);Zolpidem(Intermezzo)
 Zalepon(Sonata)
 Eszopiclone (Lunesta)
 Ramelteon(Rozerem)
Rozeremisdifferentinthatisdoesnot bindtoGABA like the others,butratherto melatoninreceptors. Adverse side
effectsincludedrowziness,dizziness,hangover,anddependence.Some of these,especiallyAmbien,are molecularly
verysimilartobenzos,thusriskof misuse anddependence.Controversyre:forshorttermrelief ormaintenanceinlong
term.
PARTII: HIV-PSYCHOTROPIC INTERACTIONS
Beginswithhepatic(liver) metabolism;InPhase I, Cytochrome P450 isthe mostcrucial.
 Cytochrome P450 systemisaffectedbyage,hormones,nutrition,drughalf-life,stress,drugdosages,hepatic
bloodflow,andliverdisease
 In HIV care, Norvir(ritonavir) isthe biggestoffender(causesmostinteractions)
Three importantterms:
 Substrate - any drug metabolizedbyP450 enzymes
 Inhibitor- anydrug that inhibitsthe metabolismof aP450 substrate (strong,moderate,weak)
 Inducer- anythingthatincreasesthe amountof P450 enzymes(strong,moderate,weak)
Three waysinteractionsoccur:
 Addinhibitororinducertoexistingregimencontainingasubstrate drug
 Withdraw inhibitororinducerfromexistingregimencontainingasubstrate drug
 Addsubstrate drugto a regimencontaininganinhibitororinducer
Thisarea of clinical researchandknowledge isvastandgrowing.Forus,we needtorememberthatmostinteractions
are notclinicallysignificant;however,theydooccurandare oftenhighlyidiosyncratic/individualistic.Itis Impossibleto
memorize all interactions,sowe refertoexcellentresourcessuchas:
www.madisonclinic.org
http://hivinsite.ucsf.edu/arvdb?page=ar-00-02
http://www.columbia.edu/cu/hivmentalhealthtraining/pdf/Drug_Interactions.pdf
http://nynjaetc.org/documents/2013_PsychGuide_WEB.pdf
5
6
PARTIII: QUESTIONS FOR COUNSELORS AND THERAPISTS
Often,the firstmentionof psychotropicmedicationcomesfromthe counselorortherapistwhoknowsthe client’s
historyandcurrent symptompicture best.Inthisrole,the counselorortherapistservesasthe bridge orliaisoninthe
relationshipbetweenthe clientandthe prescribing physician.Thus,we are ina positiontobe askeda lotby clients,but
alsoto be helpful andfacilitative tophysicians. Some waystoenhance these skills:
 Be able topresentan accurate and concise case presentation,if able.(Thistakestrainingandpractice,butis
very appreciatedbythe doc…).Or if not referringinperson,be able tostate specificclinical issues,
emotional/cognitive/behavioral disturbances thatyoufeel maybenefitfromfurtherevaluation.Avoid phrasing
referralsvaguely,forexample:“seemsdepressed,please evaluate…”
 Take time to followupwiththe prescribingphysician,atminimumtothankhim/herforthe assistance,butalso
to reportwhat changesyouare noticinginthe clientovertime.
 You don’tneedtoplayphysician,PA,ornurse,butit’sveryhelpful tobe an informativetherapistwithgood
knowledge of history,especiallyprior medications,adherencehistory/pattern,andanysubstance
abuse/addictionissuesthatthe clientislikelytominimize oravoidintheirconsultation withthe physician.
 Consultthe pharmacist;oftenmore knowledgeable andlesstime-pressured thanphysicians;notcriticizing,just
theirtraining/FTjob.Underutilizedresource!
 Expandor include youreducationaboutmulticultural issuesastheyrelate topsychiatryandmedications.
Dependingonnationality,culture,orlevelof acculturation,some clientsperceive psychiatristsasa lastresort
for “crazy people”andyouwill encounterresistance. Alternatively,some culturestendtodescribe their
psychological paininsomaticorphysical terms.Inthiscase,providingaconsultationwitha“real doctor”could
be helpful andavaluable in-road.
It’s importantforus to be readyto facilitate answeringquestionsclientsmighthave aboutmedications,especiallyif they
are unfamiliarwithpsychiatry orare relativelyuneducatedorbiasedagainst psychotropicmedications. There are no
specific,completelyrightor wrong answers to the questions below,and each clientisunique.But there are some
good responses.Let’swork togetherto see how we might approach them.
 Why doI needmedication?AmI thatbad/crazy?
 How doesthismedicationwork;howwillithelpme?
 Will thismedicine allowme tofeel atall?Idon’twant to be a robot or “un-feeling.”
 How longdoI have totake it?I don’twant to be on psychmedicationforthe restof my life.
 What are the side effectsof thismedicine?Will itmake myHIV (orother medical condition) worse?
 What if it doesn’twork/help?ThenwhatdoIdo?
 Can I stopit if I want to? Isthismedicationaddictive?
 What if the doctor justkeepsaddingother medicinestotreatthe side effectsof the original one?
 Is itexpensive?HowamI goingto payfor this?
 Aren’tthere more natural or homeopathicthingsforme totake?
 Othersyouhave encountered?...
Acknowledgements:
Murray Bennett, MD, FRCPC; Director Psychiatry Madison Clinic and Harborview Medical Center
Karina K. Uldall, MD, MPH; Department of Psychiatry, UW School of Medicine
Neil E. Whicker, MD, Grady Infectious Disease Program, Emory University

More Related Content

PDF
Pharmacotherapy of Drug Abuse or Addiction (Intoxication and Withdrawal Syndr...
PPT
Anti depressants
PPT
Anti depressants and mood stabilizers
PPTX
Antidepressants
PDF
Drug abuse
PPT
Anti depressant agents
PPT
Antidepressant
PPT
Chapter 13 Psychiatric Medications
Pharmacotherapy of Drug Abuse or Addiction (Intoxication and Withdrawal Syndr...
Anti depressants
Anti depressants and mood stabilizers
Antidepressants
Drug abuse
Anti depressant agents
Antidepressant
Chapter 13 Psychiatric Medications

What's hot (20)

PPT
05 antidepressants by ravikiran
PPTX
Antidepressants
PPT
NurseReview.Org - Psychotherapeutic Agents Updates (lesson 1 pharmacology)
PPTX
Opioids
PPT
Seminar On Antidepressants
PDF
Antidepressants ppt final
PPSX
Cns stimulants & drugs of abuse
PPTX
Psychopharmacology of Antidepressants, Mood Stabilizers and Antipsychotics
PPT
anti-psychotic drugs
PPTX
Geriatric Pharmacotherapy - Health Psychopharmacology for Therapists
PPTX
General psychopharmacology
PPT
Anti depressants
PPT
Classification drug act on nervous system
PPTX
CNS - disorders , symptoms and treatment
PPTX
Antidepressants
PPTX
Anti depressant drugs
PPTX
ANTIDEPRESSANTS
PPT
Anti depressant and its classifications
PPTX
An overview of atypical anti depressants
PPT
Antidepressants
05 antidepressants by ravikiran
Antidepressants
NurseReview.Org - Psychotherapeutic Agents Updates (lesson 1 pharmacology)
Opioids
Seminar On Antidepressants
Antidepressants ppt final
Cns stimulants & drugs of abuse
Psychopharmacology of Antidepressants, Mood Stabilizers and Antipsychotics
anti-psychotic drugs
Geriatric Pharmacotherapy - Health Psychopharmacology for Therapists
General psychopharmacology
Anti depressants
Classification drug act on nervous system
CNS - disorders , symptoms and treatment
Antidepressants
Anti depressant drugs
ANTIDEPRESSANTS
Anti depressant and its classifications
An overview of atypical anti depressants
Antidepressants
Ad

Viewers also liked (20)

PDF
Revenue_Cycle_Management
PPTX
Historia del automovil
PPTX
Delito informatica
PDF
China kmr bearing manufacturer
DOC
Deepak Mysore Nagaraj (1)
ODP
Balagarden
PPTX
hrm case analysis of magnum engineering pvt.ltd
PDF
DivvyCloud BotFactory Webinar | Cloud Automation
PPTX
Mapa cultural del ecuador provincias pichincha guayaquil azuay , loja
DOCX
Ali Agha
DOCX
NC & JS Working Draft 2
PPTX
aplicación de la ciencia y la tecnologia
PPTX
PPTX
PPTX
Algoritmo
PDF
BROCHURE INGLES 5 FUEGOS
PDF
Normalizacion de registros
PDF
NAB Lessons Learned Paper Greig 2015
Revenue_Cycle_Management
Historia del automovil
Delito informatica
China kmr bearing manufacturer
Deepak Mysore Nagaraj (1)
Balagarden
hrm case analysis of magnum engineering pvt.ltd
DivvyCloud BotFactory Webinar | Cloud Automation
Mapa cultural del ecuador provincias pichincha guayaquil azuay , loja
Ali Agha
NC & JS Working Draft 2
aplicación de la ciencia y la tecnologia
Algoritmo
BROCHURE INGLES 5 FUEGOS
Normalizacion de registros
NAB Lessons Learned Paper Greig 2015
Ad

Similar to PSYCHOPHARM PRESENTATION revised newest (20)

PPT
Antidepressants. Mood Stabilizers. Psychostimulants
PPTX
9. Bipolar Disorder.pptx for pharmacy students
PPT
Anti depression
DOC
Affective disorders
PPT
Depression
PPT
Antidepressants Tca Ssri
PPTX
anti depressants.pptxxxxxxxxxxxxxxxxxxxxxxxxx
PPT
Anti depressant , antidepressant
PDF
Mood Stabccccccccccffffffffddddilizers.pdf
PPTX
Psycho pharmacological agents.
PPT
Reward system (1) (1) (1)
DOCX
Major depressive disorder
PPTX
neuronal medication pharmacology for cns disorder.pptx
PPTX
Antidepressants
PPTX
Advancement in anti-depression drugs
PPT
Depression
PPT
Atidepressant,,,,readiHGGGGGGGGGGGGGGGGGGGGGGGGGGng.ppt
PPT
Basic Pharmacology of Antidepressants.ppt
PPTX
Mood stabilising agents
Antidepressants. Mood Stabilizers. Psychostimulants
9. Bipolar Disorder.pptx for pharmacy students
Anti depression
Affective disorders
Depression
Antidepressants Tca Ssri
anti depressants.pptxxxxxxxxxxxxxxxxxxxxxxxxx
Anti depressant , antidepressant
Mood Stabccccccccccffffffffddddilizers.pdf
Psycho pharmacological agents.
Reward system (1) (1) (1)
Major depressive disorder
neuronal medication pharmacology for cns disorder.pptx
Antidepressants
Advancement in anti-depression drugs
Depression
Atidepressant,,,,readiHGGGGGGGGGGGGGGGGGGGGGGGGGGng.ppt
Basic Pharmacology of Antidepressants.ppt
Mood stabilising agents

PSYCHOPHARM PRESENTATION revised newest

  • 1. 1 Understanding the Basics of Psychopharmacology Andrew Blalock, Ph.D. Positive Impact, January 2015 WHY THIS TRAINING?  Depression inhighrisk populations,>2foldincrease  PTSD high-riskpopulations:women,prisoners,minorities  Dementia decreased withART,butprevalence of MCMD andHAD?  Bipolar primary& secondary, 10 x higher  Schizophrenia inat-riskpopulation, 2-10x higher PRIMARY NEUROTRANSMITTER SYSTEMS PARTI: Commonly PrescribedMedications (listsare not exhaustive) ANTIDEPRESSANTS Oldermedicationslike tricyclicantidepressants (TCAs) and monoamineoxidase inhibitors (MAOIs)are rarelyused anymore,though TCAsare nowusedfornon-specificorpsychogenicpaindisorders. We typicallydonotsee these meds regularly here atPI. *= lowestrates of studiedinteractionswith various HIV meds;some are insufficientlystudiedtodate Selectiveserotoninreuptakeinhibitors (SSRIs)workbyincreasingthe amountof serotonin,the neurotransmittermost associatedwithmood.  Citalopram(Celexa)*  Escitalopram(Lexapro)*  Paroxetine (Paxil)  Fluoxetine (Prozac)  Fluvoxamine (Luvox)
  • 2. 2  Sertraline (Zoloft)*  Side Effects:Sexual problemsincludinglow sexdrive,ED, orinabilitytohave anorgasmare commonbut often reversible,dizziness,headaches,nausearightafteradose,insomnia,feelingjittery;some inducedmania(rare) Serotonin-norepinephrine reuptake inhibitors (SNRIs);increase the levelsof the neurotransmittersserotoninand norepinephrineinthe brain.  Desvenlafaxine (Pristiq)  Duloxetine (Cymbalta)  Venlafaxine(Effexor)  Side Effects:drowsiness,fatigue,blurredvision,lightheadedness, strange dreams,constipation,fever/chills, headache,drymouth,nausea,+/- appetite,sweating,BPchange (Cymbalta) Serotonin modulatorsandstimulators (SMSs);thesedrugsactpartly as serotoninreuptakeinhibitors andagonize or antagonize various serotoninreceptors.  Vilazodone(Viibryd)  Vortioxetine(Brintellix) Others  Remeron(Mirtazapine)  Wellbutrin(Buproprion)  Buspar (Buspione)  Ketamine  Almostanymedicationinvolvedwithserotoninregulationhasthe potentialtocause serotonintoxicity (serotonin syndrome) –markedbysome of the following: mania,restlessness,agitation,emotionallability, insomniaandconfusion. Althoughserious,itisnotcommon,generallyonlyappearingathighdosesorwhile on othermedications.  Pregnancycontraindications –determiningextentisdifficultaspregnanciesduringdepressionare atsome risk anyway.  Discontinuationsyndrome –veryrare withnewermedications(v.TCAsandMAOIs).  Suicidal thoughts/behaviors –rare, butreported,esp.inthose under24yo;overall though,+ outweigh -. MOOD STABILIZERS These are usedto treat mooddisorders characterizedbyintense andsustainedmoodshifts, typically bipolardisorder, but alsoother/similarcyclicmooddisturbances.AlsousedintreatingborderlinePDandschizoaffective disorder.Mood stabilizers includemineral,anticonvulsant,andantipsychoticmedications.  Lithium-- needlabworkforlevels (therapeuticrange:0.6or 0.8-1.2 mEq/L)  Lamictal (Lamotrigine)  Tegretol (Carbamazepine)  Depakene (Valproicacid),Depakote (divalproex sodium)  Trileptal (Oxcarbazepine)  Atypical Antipsychotics -- refertosubsequentsection  Side effects:verymedspecificrangingfromlithiumtoxicityto skinconditionsandWBC.  Combinationtherapy(atypical antipsychoticwithlithiumorvalproate) showsbetterefficacyovermonotherapy inthe manicphase.  Most moodstabilizersare primarilyanti-manicagents,meaningthattheyare effective attreating maniaand moodcyclingand shifting,butare noteffectiveattreatingacute depression.Exceptions (becausetheytreat both) include lithium, Lamictal,andSeroquel.  Still,antidepressants are oftenprescribedinadditiontomoodstabilizersduringdepressivephases.
  • 3. 3 ANXIOLYTICS Whenyouare anxious,yourbrainbecomesmore active andnaturallyproducesachemical called gamma-aminobutyric acid (GABA) tomake youfeel calmer.Mostanxiolyticsworkbyboostingthisprocesshelpingtoproduce a feelingof calm,peace and overall safety. Alcohol alsoworksonGABA whichiswhyitis a primaryself-medicatingchoice for anxiety. Benzodiazepines  Alprazolam(Xanax) - avoid  Chlordiazepoxide(Librium)  Clonazepam(Klonopin)*  Clorazepate (Tranxene)  Diazepam(Valium)  Lorazepam(Ativan)*  Oxazepam(Serax)*  Temazepam(Restoril)*  Triazolam(Halcion) –avoid  Also,some SSRIs,Hydroxyzine,BetaBlockers,Neurontin;5-6othersrarelyusedandoftennot inUS  Shiftseemstobe awayfrom benzos due todependenceissues (especiallythose thatactquicklylike Xanax) otherthan foracute anxietyorinlowerdoses orin some alcohol detox protocols;Rx prn longterm?  More commonside effects,especiallyof highdoses, include drowsiness,headaches,memoryproblems(inhigh dosescan cause amnesticsyndromes),dizziness,feeling‘numb’,depersonalization/derealization,and dependence oraddiction. There isariskof a benzodiazepine withdrawalandreboundsyndromeafter continuoususage forlongerthantwoweeks,andtolerance anddependencemayoccurif patientsstayunder thistreatmentforlonger ANTIPSYCHOTICS Antipsychoticsworkbyalteringthe effectof neurotransmitters:serotonin,noradrenaline,andacetylcholine;however, dopamine isthe mainchemical thatthese medicines affect.Theycansuppressorprevent positive symptomslike a/v hallucinations,delusions,thoughtdisorder(associatedwithpsychoticspectrumdisorders),andextreme moodswings (associatedwithbipolardisorder).Firstgenerationones,introducedin1950s and used until early1990s were powerful tranquilizersassociatedwithadverse neurologicalside effects(TDandEPS – postural andmovementdisorders). Nowin additiontotreatingpsychoticsyndromes,theyare alsousedasadjunctive therapies(usuallyinlowerdoses) withan antidepressantformooddisorders. Atypicals - second generation  Aripiprazole(Abilify)  Lurasidone (Latuda)  Olanzapine (Zyprexa)  Quetiapine (Seroquel)  Risperidone(Risperdal)  Ziprasidone (Geodon)  Asenapine (Saphris)  Paliperidone (Invega)  Side Effects: all atypical antipsychoticscarrythe possible riskforcausingweightgainandraisingbloodsugar, cholesterol,andtriglyceride levels,whichmustbe periodicallymonitoredduringtreatment. Some antipsychotics -- typical and atypical -- can cause heartrhythm problemsthatmayrequire monitoringbyadoctor.
  • 4. 4 HYPNOTICS(sleep) Alsocalledsoporificdrugs,thisisa classof psychoactive drugs whose primaryfunctionisto induce sleep andtobe used inthe treatmentof insomnia,earlyandmiddle. Include barbituates,quinazolinones,benzodiazepines,atypical antipsychotics,antidepressants,antihistamines,andthese more familiar:  Zolpidem(Ambien);Zolpidem(Intermezzo)  Zalepon(Sonata)  Eszopiclone (Lunesta)  Ramelteon(Rozerem) Rozeremisdifferentinthatisdoesnot bindtoGABA like the others,butratherto melatoninreceptors. Adverse side effectsincludedrowziness,dizziness,hangover,anddependence.Some of these,especiallyAmbien,are molecularly verysimilartobenzos,thusriskof misuse anddependence.Controversyre:forshorttermrelief ormaintenanceinlong term. PARTII: HIV-PSYCHOTROPIC INTERACTIONS Beginswithhepatic(liver) metabolism;InPhase I, Cytochrome P450 isthe mostcrucial.  Cytochrome P450 systemisaffectedbyage,hormones,nutrition,drughalf-life,stress,drugdosages,hepatic bloodflow,andliverdisease  In HIV care, Norvir(ritonavir) isthe biggestoffender(causesmostinteractions) Three importantterms:  Substrate - any drug metabolizedbyP450 enzymes  Inhibitor- anydrug that inhibitsthe metabolismof aP450 substrate (strong,moderate,weak)  Inducer- anythingthatincreasesthe amountof P450 enzymes(strong,moderate,weak) Three waysinteractionsoccur:  Addinhibitororinducertoexistingregimencontainingasubstrate drug  Withdraw inhibitororinducerfromexistingregimencontainingasubstrate drug  Addsubstrate drugto a regimencontaininganinhibitororinducer Thisarea of clinical researchandknowledge isvastandgrowing.Forus,we needtorememberthatmostinteractions are notclinicallysignificant;however,theydooccurandare oftenhighlyidiosyncratic/individualistic.Itis Impossibleto memorize all interactions,sowe refertoexcellentresourcessuchas: www.madisonclinic.org http://hivinsite.ucsf.edu/arvdb?page=ar-00-02 http://www.columbia.edu/cu/hivmentalhealthtraining/pdf/Drug_Interactions.pdf http://nynjaetc.org/documents/2013_PsychGuide_WEB.pdf
  • 5. 5
  • 6. 6 PARTIII: QUESTIONS FOR COUNSELORS AND THERAPISTS Often,the firstmentionof psychotropicmedicationcomesfromthe counselorortherapistwhoknowsthe client’s historyandcurrent symptompicture best.Inthisrole,the counselorortherapistservesasthe bridge orliaisoninthe relationshipbetweenthe clientandthe prescribing physician.Thus,we are ina positiontobe askeda lotby clients,but alsoto be helpful andfacilitative tophysicians. Some waystoenhance these skills:  Be able topresentan accurate and concise case presentation,if able.(Thistakestrainingandpractice,butis very appreciatedbythe doc…).Or if not referringinperson,be able tostate specificclinical issues, emotional/cognitive/behavioral disturbances thatyoufeel maybenefitfromfurtherevaluation.Avoid phrasing referralsvaguely,forexample:“seemsdepressed,please evaluate…”  Take time to followupwiththe prescribingphysician,atminimumtothankhim/herforthe assistance,butalso to reportwhat changesyouare noticinginthe clientovertime.  You don’tneedtoplayphysician,PA,ornurse,butit’sveryhelpful tobe an informativetherapistwithgood knowledge of history,especiallyprior medications,adherencehistory/pattern,andanysubstance abuse/addictionissuesthatthe clientislikelytominimize oravoidintheirconsultation withthe physician.  Consultthe pharmacist;oftenmore knowledgeable andlesstime-pressured thanphysicians;notcriticizing,just theirtraining/FTjob.Underutilizedresource!  Expandor include youreducationaboutmulticultural issuesastheyrelate topsychiatryandmedications. Dependingonnationality,culture,orlevelof acculturation,some clientsperceive psychiatristsasa lastresort for “crazy people”andyouwill encounterresistance. Alternatively,some culturestendtodescribe their psychological paininsomaticorphysical terms.Inthiscase,providingaconsultationwitha“real doctor”could be helpful andavaluable in-road. It’s importantforus to be readyto facilitate answeringquestionsclientsmighthave aboutmedications,especiallyif they are unfamiliarwithpsychiatry orare relativelyuneducatedorbiasedagainst psychotropicmedications. There are no specific,completelyrightor wrong answers to the questions below,and each clientisunique.But there are some good responses.Let’swork togetherto see how we might approach them.  Why doI needmedication?AmI thatbad/crazy?  How doesthismedicationwork;howwillithelpme?  Will thismedicine allowme tofeel atall?Idon’twant to be a robot or “un-feeling.”  How longdoI have totake it?I don’twant to be on psychmedicationforthe restof my life.  What are the side effectsof thismedicine?Will itmake myHIV (orother medical condition) worse?  What if it doesn’twork/help?ThenwhatdoIdo?  Can I stopit if I want to? Isthismedicationaddictive?  What if the doctor justkeepsaddingother medicinestotreatthe side effectsof the original one?  Is itexpensive?HowamI goingto payfor this?  Aren’tthere more natural or homeopathicthingsforme totake?  Othersyouhave encountered?... Acknowledgements: Murray Bennett, MD, FRCPC; Director Psychiatry Madison Clinic and Harborview Medical Center Karina K. Uldall, MD, MPH; Department of Psychiatry, UW School of Medicine Neil E. Whicker, MD, Grady Infectious Disease Program, Emory University